Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Mesoblast Ltd (NASDAQ:MESO)

5.48
Delayed Data
As of Dec 15
 0.00 / 0.00%
Today’s Change
4.80
Today|||52-Week Range
12.50
+2.43%
Year-to-Date
No recent news for Mesoblast Ltd.

Today’s Trading

Previous close5.48
Today’s open5.50
Day’s range5.32 - 5.59
Volume50,603
Average volume (3 months)37,778
Market cap$511.7M
Data as of 4:00pm ET, 12/15/2017

Growth & Valuation

Earnings growth (last year)-1,605.50%
Earnings growth (this year)+8.24%
Earnings growth (next 5 years)+24.00%
Revenue growth (last year)-95.31%
P/E ratioNM
Price/Sales326.56
Price/Book0.91

Competitors

 Today’s
change
Today’s
% change
IVCInvacare Corp0.000.00%
RTIXRTI Surgical Inc0.000.00%
SIENSientra Inc0.000.00%
OFIXOrthofix Internation...0.000.00%
Data as of 4:03pm ET, 12/15/2017

Financials

Next reporting dateFebruary 14, 2018
EPS forecast (this quarter)-$0.22
Annual revenue (last year)$1.9M
Annual profit (last year)-$76.8M
Net profit margin-3,951.39%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer, MD &
Executive Director
Silviu Itescu
Chief Financial Officer
Paul Hodgkinson
Corporate headquarters
Melbourne, Victoria (vic)

Forecasts